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Abstract 
Both an excess and a paucity of adipose tissue can result in major health 
complications such as heart disease, stroke and increased cancer risk. CD24 is a cell 
surface receptor involved in the regulation of cell survival. Previous research suggests 
that CD24 is expressed on cells that can become adipocytes, however the function of 
CD24 on these cells is unclear. The goal of this thesis was to detennine if CD24 directly 
regulates adipogenesis by examining its expression and regulation on pre-adipocytes in 
vitro and in vivo. CD24 mRNA and protein expression was found to increase upon 
induction of adipogenesis in vitro in 3T3-L I pre-adipocytes, followed by a decrease as 
the adipocyte matured. This increase in CD24 expression was mediated by cyclic 
adenosine monophosphate. Antibody-mediated clustering of CD24 resulted in decreased 
mRNA expression of late adipogenic markers and increased expression of CD24 itself, 
suggesting the presence of a positive feedback loop. Overall, the data presented here 
suggest that there is an inverse correlation between CD24 expression and adipocyte 
differentiation and/or function. This work has implications for improving the health of 
obese and lipodystrophic patients. 
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1.0 Literature Review 
White adipose tissue (W AT) plays a critical role in energy balance, homeostasis 
and metabolism. It acts as a major energy reservoir, storing excess energy as triglycerides 
(TG) and mobilizing TG during energy deprivation. However, dysregulation of W AT 
production can cause major health problems. Obesity, the over production of adipose 
tissue, is associated with heart disease, stroke, type 2 diabetes, and certain types of cancer 
(Mokdad et al. , 2003). Conversely, lipodystrophy, the wasting of adipose tissue, a 
condition commonly seen in cancer patients and those receiving anti-retroviral treatments, 
can result in insulin resistance and diabetes, and is a positive risk factor for death 
(Hadigan et a!. , 200 I). Therefore, to develop better therapeutic strategies to combat the 
dysregulation of adipose tissue, it is important to fully understand the molecular 
regulation of adipose tissue production, known as adipogenesis. 
1.1 White Adipose Tissue 
There are two distinct types of adipose tissue in mammals, W AT and brown 
adipose tissue (BAT) (Cannon and Nedergaard, 2004). While both types of adipose tissue 
can store lipid, they have entirely different functions . BAT, found abundantly in infants, 
generates heat through non-shivering thennogenesis by uncoupling cellular respiration 
(Cannon and Negergaard, 2004). W AT is not only the main storage depot for energy, but 
it is also a metabolic and endocrine organ, secreting hormones such as leptin and 
adiponectin to control appetite and glucose levels, as well as several inflammatory 
cytokines such tumor necrosis factor alpha (TNF-a) and interleukin-6 (IL-6) (Friihbeck et 
al. , 200 1). 
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W AT is composed of multiple cells types including adipocytes, pre-adipocytes, 
macrophages, vascular, and epithelial cells (Cinti, 2005). The stromal vascular fraction 
(SVF) of adipose tissue, obtained through centrifugation of collagenase-digested W AT, 
contains pre-adipocytes and adipose-derived stem cells (ADSC) that can be induced to 
differentiate into adipogenic, chondrogenic, myogenic, and osteogenic lineages (Zuk et 
al., 2001). In addition to pre-adipocytes and ADSCs, the SVF contains 
macrophages/monocytes, whose presence in adipose tissue is associated with the chronic 
low-grade inflammation that occurs during obesity (Bastard et al., 2006). Other cells 
found in the SVF include fibroblasts , progenitor endothelial cells and T regulatory cells 
(Riordan et al., 2009). The SVF is commonly used as an in vitro system to study 
adipocyte development (see section 1.2.2.3). 
White adipocytes are unilocular, containing a large lipid droplet, surrounded by a 
thin cytoplasm, with the nucleus located on the periphery. W AT can respond to an 
increase in energy intake by storing the excess energy as lipid to increase adipocyte size 
(hyperplasia) and/or by generating new adipocytes to increase the adipocyte cell 
population (hypertrophy) (Lane and Tang, 2005). While mature adipocytes are post-
mitotic, approximately 10% of adipocytes are replaced every year suggesting an 
adipocyte precursor population source is maintained throughout life (Spalding et al. , 
2008). However, the identity and localization of these precursors remains unknown. 
1.2 Models of adipogenesis 
There are several different models used to study adipogenesis. Insights to the 
etiology of obesity, as well as the development of therapeutics to combat obesity, have 
been accomplished from in vivo animal models, including diet-induced obesity in rodents, 
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and transgenic models such as in the ob/ob (obese) mouse, the agouti mouse, the Zuker 
fatty rat and the Wistar fatty rat. In vitro cell cul ture systems have been widely used to 
study adipocyte differentiation and have been a useful tool in detennining the 
transcriptional regulation of adipogenesis. 
1.2. 1 In vivo models of adipogenesis 
1.2.1.1 Diet induced obesity 
Obesity induced with a high fat diet (HFD) is often used in obesity and adipocyte 
research. The C57BL/6 mouse is the most commonly used animal for diet induced obesity 
studies as they exhibit abnormalities similar to that of human metabolic syndrome when 
fed a HFD (Collins et al. , 2004). Exposure to a high fat and high carbohydrate diet 
produces obesity in male C57BL/6J mice that bad elevated concentrations of serum 
insulin, glucose and leptin, and low serum triglycerides (Coll ins et al. , 2004; Guo et al. , 
2009; Petro et al. , 2004). Female C57BL/6J will become obese when fed a HFD, however 
they will not exhibi t glucose intolerance and hyperinsulinemia (Pettersson et al. , 2012). 
Sand mice and spiny mice respond to a HFD in a similar manner as C57BL/6 mice and 
are also often used in diet induced obesity research, as well as Sprague Dawley and Long 
Evans rats (Hunt et al. , 1976; Levin et al. , 1997). Although diet induced obesity in 
rodents is commonly used, it must be noted that different strains can have differing 
responses to a HFD. When fed a HFD, C57BL/6 and AKR mice have similar weight gain, 
but only C57BL/6 will exhibit glucose intolerance, while the SWR/J and A/J mice are 
resistant to diet induced obesity (Prpic et al., 2002; Gallou-Kabani et al. , 2007). 
Furthennore, even within the same strain, differences in phenotypical responses to a HFD 
have been observed. Differential expression of adipogenic genes has been found in 
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C57BL/6 mice before addition of a HFD suggesting that some mice are predisposed to be 
' high gainers', gaining more weight when fed a HFD then ' low gainers' of the same litter 
(Koza et al., 2006; Pecoraro et al., 2006). In addition, adiposity during the first 3 weeks of 
a HFD does not coiTelate with difference in either food intake or feeding efficiency (Koza 
et al., 2006). 
1.2. 1.2 Ob/Ob mouse 
The ob/ob mouse, or obese mouse, was discovered by chance in a colony at the 
Jackson Laboratory in 1949 (Ingalls et al. , 1950). It took over 40 years to discover, 
through positional cloning, that a spontaneous single base deletion in the coding region of 
the leptin gene was responsible for the obese mutation. (Zhang et al , 1994). Leptin is 
produced in adipose tissue and plays a central ro le in appetite regulation. As a result, 
ob/ob mice have uncontrolled food intake and become massively obese (Friedman and 
Halaas, 1998). At birth, ob/ob mice are indistinguishable from their littenn ates, but after 2 
weeks, they become heavier and develop hyperinsu linemia. While leptin deficiency is 
very rare in humans, ob/ob mice will exhibit many of the metabolic abnormalities of 
obesity and diabetes such as insulin resistance, non-fasting hyperglycemia, impaired 
glucose intolerance and adipose tissue abnormalities (Lindstrom, 2007). 
1.2.1.3 Agouti mouse 
The agouti gene is normally transiently expressed in the follicular melanocyte, 
where it functions to control the production of pigmentation (Millar et a l., 1995). Its 
mutation however, gives rise to obese, yellow mice. There are five dominant agouti 
mutations, the most common and useful model of obesity being the lethal yellow mutant 
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mouse, which is characterized by the deletion of 120-170 kb genomic DNA, resulting in 
ubiquitous expression ofthe agouti gene (Duhl et al. , 1994; Michaud et al., 1994). While 
the mechanism of agouti modulation of pigmentation is largely understood, the 
mechanism of agouti action in obesity is not. One proposal is that the agouti mutation 
results in increased expression of fatty acid synthase and stearoyl-CoA desaturase, two 
key enzymes in fatty acid synthesis (Jones et al. , 1996), while another is that the agouti 
mutation results in disruption of the melanocortin-4 receptor, expressed in the brain, 
causing hyperphagia and hyperinsulinemia (Huszar et al. , 1997). Yellow mutant mice 
develop obesity, hyperinsulinemia, hyperglycemia and increased likeliness to develop a 
variety of spontaneous and induced tumours (Kiebig et al., 1995). The agouti mouse is 
highly relevant to human obesity as the agouti gene is overexpressed in the adipose tissue 
of obese patients with type II diabetes (Smith et al. , 2003). 
1.2.1.4 Zucker fatty rat 
The Zucker fatty rat share many similarities with obese humans who have insulin-
resistance and type II diabetes, as well as a strong genetic component in the transmission 
of obesity (Alonso-Galicia et al. , 1996). The Zucker fatty rat contains a spontaneous 
recessive mutation in the ' fatty (fa) gene ', shown to be the leptin receptor gene (Zucker, 
1965; Ogawa et al. , 1995). Like the ob/ob mouse, this mutation causes the Zucker fatty rat 
to be hyperphagic and therefore develop early onset obesity, hyperinsulinemia, 
hypercholesterolemia, hyperlipidemia and hypertension (Kurtz et al. , 1989). The Zucker 
fatty rat exhibits insulin resistance, although showing normal blood sugar levels, and is 
commonly used as a model of obese metabolic syndrome. 
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1.2.1.5 Wistar fatty rat 
The Wistar fatty rat was developed in 1981 by crossing the obese Zucker fatty 
rat and the Wistar-Kyoto rat, transferring the ' fattty (fa) gene' (Ikeda et al., 1981). The 
Wistar fatty rat develops obesity and obesity-related symptoms, such as hyperinsulinemia, 
hyperlipemia, and hypertension in a manner similar to the obese Zucker fatty rat. Male 
Wistar fatty rats display obesity 3 weeks after bit1h and develop severe hyperglycemia, 
glucosuria, and polyuria as early as 8 weeks of age. Female Wistar fatty rats, however, 
only demonstrate some insulin resistance and mild glucose intolerance (Kava et al. , 1989). 
1.2.2 In vitro models of adipogenesis 
1.2.2.1 3T3-Ll and 3T3-F442A cell lines 
The transcriptional cascade regulating adipogenesis has been extensively studied 
through the use ofthe mouse 3T3-Ll and 3T3-F442A pre-adipocyte cells lines. The 3T3-
L 1 and 3T3-F442A cell lines are well-established pre-adipocyte cell lines that reiterate the 
development of adipocytes in vivo (Rosen and Spiegelman, 2006). Both cells lines were 
isolated from Swiss 3T3 cells derived from disaggregated 17-1 9 day mouse embryos 
(Green and Kehinde, 1975). With addition of an adipogenic cocktail containing 
supraphysiological levels of 3-isobutyl-1-methylxanthine (IBMX), dexamethasone (DEX) 
and insulin, 3T3-Ll cells wi ll differentiate into mature, lipid filled adipocytes (Green and 
Kehinde, 1974). Compared to the 3T3-L l cell line, the 3T3-F442A cell line is committed 
at a later stage in adipocyte development and requires only insulin to differentiate. When 
implanted into nude mice, both 3T3-Ll and 3T3-F442A cells will produce fat pads that 
are histologically and biochemically identical to that of the host (Green and Kehinde, 
1979). Both cell lines were developed through clonal expansion and therefore contain one 
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single cell type that responds homogenously to treatments. In addition, these cells are 
immortalized, allowing for a consistent source of pre-adipocytes, although capacity to 
differentiate into adipocytes declines with increasing number of passages. For these 
reasons, the 3T3-Ll and 3T3-F442A cells line are the most frequently used in vitro cell 
lines in adipocyte research. 
1.2.2.2 Ob l 7 cell line 
The Ob 17 cell line is derived from adipocyte precursors present in the epididmyal 
fat pads of the genetically obese ob/ob mouse (Negrel et at., 1978). With respect to the 
3T3-Ll and 3T3-F442A cell lines, the Obl7 cell line is used less frequently in adipocyte 
research. The Ob 17 cell line represents a much later pre-adipocyte commitment stage then 
the 3T3-Ll and 3T3-F442A cells lines and requires only insulin to differentiate into 
mature adipocytes (Negrel et at. , 1978; Vannier et at., 1996). When implanted into nude 
mice, Ob 17 cells will also develop into fat pads that are histologically and biochemically 
identical to that of the host (Green and Kehinde, 1979). 
1.2.2.3 Stromal Vascular Fraction (SVF) 
The SVF is isolated after the centrifugation of collagenase treated W AT, causing 
the mature white adipocytes to float, while the SVF fonns a pellet. It is commonly used to 
study pre-adipocyte development and is one of the closest in vitro representations of 
human adipogenesis because instead of containing just one cell type, the S VF contains 
multiple different cells (see section 1.1 ). ADSCs from the SVF can be induced to 
differentiate into adipocytes, osteoblasts, chondrocytes, and myocytes under specific, 
optimized conditions (Zuk et at. , 2001 ). Identification of the different cells types within 
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the SVF can be accomplished using clusters of differentiation (CD) markers. Adipose 
derived stem cells are defined by the phenotype CD31-. CD34+, CD45-, CD90+, CD 105-, 
CD 145-, while endothelial cells are defined by CD34+/CD31 + and macrophages by 
CD 14 and CD31, allowing for the selection of specific cell types in the SVF by magnetic 
bead sorting or flow cytometry (Sengenes et al. , 2005; Annani et al. , 2010). Injection of 
CD29+, CD34+,Sca1 +,CD24+ cells from the SVF into mice that genetically lack WAT, 
resulted in growth of W AT (Rodeheffer et al. , 2008). Studies using the SVF have 
demonstrated that pre-adipocyte differentiation is defined by several factors including 
species, location of adipose depot, and donor age (Poulous et al. , 2008). 
1. 2.3 Chosen Models of Adipogenesis used in this Thesis 
For all in vitro experiments in this thesis, the 3T3-Ll pre-adipocyte cell line was 
used. The 3T3-L 1 cell line is highly characterized and well established, making it an ideal 
cell line to study pre-adipocyte development. Diet induced obesity in C57BL/6 mice was 
the chosen model for the in vivo studies as these mice are highly susceptible to obesity 
when fed a HFD. 
1.4 Regulation of Adipogenesis 
1. 4.1 Adipocyte development 
The development from pre-adipocyte to mature adipocyte involves four stages -
growth arrest, clonal expansion, early differentiation and tenninal differentiation, each 
stage characterized by a unique pattern of gene expression (Macdougland and Lane, 
1995). Pre-adipocytes, in cell culture, must undergo growth arrest at the GO/G 1 cell cycle 
boundary before differentiating (Reichert and Eick, 1999). It is growth atTest, and not 
8 
cell-cell contact, that is required for adipocyte differentiation. The 3T3-F442A pre-
adipocyte cell line can still undergo differentiation when shifted to a methylcellulose-
stabilized suspension culture (Pairault and Green, 1979), and primary rat pre-adipocytes 
plated at low density in serum-free medium can also differentiate in absence of cell-cell 
contact (Gregoire et al., 1998). 
Following growth arrest, pre-adipocytes must receive an appropriate combination 
of mitogenic and adipogenic signals before re-entering the cell cycle and undergoing at 
least 2 rounds of cell division, referred to as clonal expansion. Inhibiting clonal expansion 
will prevent differentiation. Blocking the cell cycle with aphidicolin (Reichert and Rick, 
1999), rapamycin (Yeh et al. , 1995) or roscovitine (Tang et al. , 2003) disrupts pre-
adipocyte differentiation, while disrupting the pro-adipogenic transcription factor CCAA T 
enhancer binding protein-~ (C/EBPP) prevents mitotic clonal expansion and consequently 
adipogenesis. Once clonal expansion is complete, cells will exit the cell cycle and begin 
to tenninally differentiate. 
Early and terminal differentiation is accompanied by changes in several 
transcription factors and proteins (see section 1.4.2). Dramatic modifications in adipocyte 
morphology occur where the cells change from a fibrob lastic phenotype to spherical 
shape. There are also changes in the level and types of extra cellular matrix (ECM) as 
well as the levels of cytoskeleton components. A decrease in both actin and tubulin 
precede adipocyte morphological changes (Spiegelman and Farmer, 1982) as well as a 
decrease in type I and type III procollagen (Weiner et al. , 1989) Proteolytic degradation of 
the ECM of pre-adipocytes by the plasminogen cascade is required for change in cell 
morphology, adipogenic gene expression and lipid accumulation (Selvarajan et al. , 2001). 
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During tenninal differentiation, adipocytes increase de novo lipogenesis, 
increasing the mRNA, protein and activity levels of several enzymes required for 
lipogenesis including acetyi-CoA carboxylase, stearoyi-CoA desaturase (SCD 1 ), glycerol-
3-phosphate acyltransferase, glycerol-3-phosphate dehydrogenase, fatty acid synthase, 
and glyceraldehyde-3-phosphate dehydrogenase (Spiegelman et al., 1983; Weiner et al., 
1991 ). Glucose transporters, insulin receptor number, and insulin sensitivity also increase 
during the later stage of adipogenesis (Garcia de Herreros and Birnbaum, 1989). 
1.4.2 Intracellular signalling 
The addition ofiBMX, DEX and insulin to induce 3T3-Ll differentiation, 
highlight the importance of the cyclic adenosine monophosphate (cAMP), glucocorticoid 
and insulin/Insulin-like growth factor-! (IGF-1 ) signalling pathways in adipocyte 
development. 3T3-LJ pre-adipocytes must undergo growth arrest before differentiation, 
therefore, 48 hours post-confluency, adipogenesis is induced by adding a combination of 
IBMX and DEX. IBMX is a cyclic nucleotide phosphodiesterase inhibitor that can 
stimulate adenylyl cyclase activity, resulting in increased cAMP levels (Parsons et al. , 
1988). DEX is a synthetic glucocorticoid that activates the glucocorticoid receptor and 
can also act to increase cAMP levels by decreasing expression of cAMP-
phosphodiesterase (Ahlstrom et al, 2005). Increased cAMP activates the downstream 
effectors, protein kinase A (PKA) (Taylor et al. , 1990) and exchange protein directly 
activated by cAMP (EPAC-1, EPAC-2) (de Rooij et al. , 1998). The cAMP/PKA pathway 
has been demonstrated to stimulate adipogenesis in 3T3-L 1 cells by activating the 
downstream transcription factor cAMP-responsive element-binding protein (CREB) 
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(Reusch et al., 2000), which induces expression of the C/EBP-~ (Otto and Lane, 2005). 
EPAC -1 ,-2 promotes adipogenesis via activation ofthe Ras superfamily 
protein Rap 1, as well as by enhancing IGF-1-dependent activation of protein kinase B 
(PKB) (Petersen et al. , 2008). cAMP signalling, resulting in simultaneous activation of 
PKA and EPAC-1 ,-2, is necessary for the development of adipocytes from mesenchymal 
stem cells (Jia et al., 20 L 2). Further, the synergistic activity of PKA and EPAC -1,-2 is 
required for cAMP mediated differentiation of 3T3-L 1 cells (Petersen et al., 2008). 
Forty-eight hours after IBMX and DEX addition, insulin is added to the cells, 
initiating a series of complex pathways. Addition of insulin activates the IGF -1 signalling 
pathway by recruiting and phosphorylating insulin receptor substrate proteins, leading to 
the activation of the phosphatidylinositol 3-kinase (Pl3-Kinase) pathway. Activation of 
the PI3-Kinase pathway via insulin results in further stimulation of the pro-adipogenic 
transcription factor CREB, while inhibition of PI3-Kinase blocks insulin induced 
adipogenesis. Activation of PI3-Kinase stimulates downstream PKB. Constitutively active 
PKB induces spontaneous adipogenesis in 3T3-L L pre-adipocytes (Magun et al. , 1996). 
Further, activation of the PI3-Kinase pathway aids in the regulation of glucose 
metabolism, including glucose uptake and glycogenesis, promoting de novo fatty acid 
synthesis (Satoh, 1993). 
1.4. 3 Transcriptional regulation of adipogenesis 
Two major transcription families, Peroxisome proliferator-activated receptor y 
(PPARy) and C/EBPs, control the transition through each stage of adipocyte development. 
CIEBPP and C/EBP8 are expressed early during adipogenesis, with increasing expression 
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upon addition of IBMX and DEX. The importance of C/EBP~ and C/EBP8 in 
adipogenesis is evidenced by the fact that over-expression of either protein in 3T3-Ll pre-
adipocytes accelerates adipogenesis (Wu et al., 1995). Their expression is responsible for 
the regulation of C/EBPa and PPARy, the 'master regulators ' of adipogenesis (Fig. 1) 
(Cao et al., 1991 ; Lin and Lane, 1994; Clarke et al. , 1997). 
Both C/EBPa and PPARy are transcriptionally activated by C/EBP~ and C/EBP8 
and once expressed, PPARy and C/EBPa positively regulate each others expression 
(Schwarz et al., 1997; Shao & Lazar, 1997). C/EBPa and PPARy expression is both 
necessary and sufficient to promote adipogenesis. Overexpression of C/EBPa in 3T3-L1 
pre-adipocytes induces differentiation into a mature adipocyte (Lin and Lane, 1994) while 
blocking its expression with antisense RNA inhibits adipogenesis (Lin and Lane, 1992). 
Further, mice with a homozygous deletion of the C/EBPa gene have dramatically reduced 
accumulation of W AT (Wang, 2005). Overexpression of PPARy in fibroblastic cells 
induces growth arrest (Tontonoz et al. , 1994) and adipogenesis (Sandouk et al. , 1993) 
while knockout ofPPARy in mature adipocytes in vivo leads to death of adipose 
tissue (Rosen and Spiegelman, 2006). In addition, the development of white adipose 
tissue in chimeric mice composed of wild-type and PPARy ( -/-) embryonic stem cells, 
have a strong preference toward PPARy expression (Rosen et al. , 1999). 
There are several other transcription factors and proteins that play a role in 
adipogenesis. Pre-adipocyte factor 1 (Pref- 1) is an inhibitor of adipocyte differentiation 
that is highly expressed in pre-adipocytes, but not detectable in mature adipocytes (Smas, 
1993). At the pre-adipocyte stage, expression of Pref-1 actively inhibits adipocyte 
maturation via downregulation ofC/EBPa and PPARy2 expression (Kim, 2007). 
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Fig. 1. Transcriptional regulation of adipogenesis in 3T3-Ll cells. IBMX and DEX and insulin 
induce a transcriptional cascade involving several proteins as described in section 1.4.2. IBMX and 
DEX increase levels of cyclic adenosine monophosphate (cAMP), resulting in phosphorylation 
(represented by a lower case p) of cAMP response element-binding protein (CREB) and activation 
of CCAAT/enhancer binding protein ~ and 8 (C/EBP~, C/EBP8). Krupple like factor 5 (KLF5), 
KLF4 and Krox20, and KLF5 are pro-adipogenic, working together with C/EBP~ and C/EBP8 to 
induced C/EBPa and PPARy expression, the master regulators of adipogenesis, while KLF2 and 
KLF3 are anti-adipogenic. KLF6 is pro-adipogenic, inhibiting pre-adipocyte factor l (Pref-1 ) 
expression, abolishing its inhibitory effects on C/EBPa and PPARy . Early B cell factor- ! (EBF l ) 
and sterol regulatory element binding transcription factor l (SREBP 1 c) promote differentiation 
while forkhead transcription protein FOXO 1 (FOXO 1 ), globin transcription factors 2 and 3 
(GATA2, GATA3), and WNT/~-catenin are inhibitory. Circles represent major transcription factors 
(TF), while squares represent other regulatory TF involved in adipogenesis. Green indicates pro-
adipogenic factors, while red represents anti-adipogenic factors. 
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Increased expression of the pro-adipogenic transcription factor, kruppel-like factor 6 
(KLF6), downregulates Pref-1 expression to promote adipogenesis (Li, 2005). Several 
other members of the KLF family also play a role in adipogenesis. KLF5, KLF4 and 
KLF 15 are early pro-adipogenic transcription factors, working with C/EBPP and C/EBP8 
to induce adipogenesis. KLF5 is expressed early during adipogenesis, where C/EBPP and 
C/EBP8 bind directly to the KLF5 promoter, and work together to facilitate the expression 
ofPPARy (Oishi et al., 2005). KLF4 binds to the C/EBPP promoter, and along with Krox 
20 (Chen et al., 2005), increases expression of C/EBPp, promoting adipogenesis (Birsoy 
et al. , 2008). Expression of KLF 15 is induced by C/EBPP and C/EBP8 at the initial stages 
of adipogenesis and KLF 15 works synergistically with C/EBPa to increase PP ARy 
expresion (Mori et al. , 2005). KLF2 and KLF3, however, are anti-adipogenic, and 
function directly on PPARy and C/EBPa (Sue et al. , 2008). Constitutive expression of 
KLF2 results in decreased expression of PPARy, but has no effect on C/EBPP and 
C/EBP8 expression (Banerjee et al. , 2003), whi le the overexpression of KLF3 blocks 
adipocyte differentiation due to its direct association with the C/EBPa promoter (Sue et 
al. , 2008). 
In addition, early B cell factor-1 (EBF 1) (Jimenez et al. , 2007) and sterol 
regulatory element binding transcription factor I (SREBP I c) (Kim et al. , 1998) promote 
differentiation, while forkhead transcription protein FOXO 1 (FOXO 1) (Nakae et al.,2003) 
and globin transcription factors 2 and 3 (GATA2 and GATA3) (Jack and Crossley, 2010) 
are inhibitory. Furthennore, WNT/P-catenin signalling inhibits adipogenesis by blocking 
induction of PPARy and C/EBPa (Christodoulides et al. , 2009). Addition of insulin to 
3T3-L1 pre-adipocytes increases expression ofpro-adipogenic SREBPlc, while it inhibits 
anti-adipogenic FOXO I via PKB (Kim et al. , 1998; Nakae et al. , 2003). Thus, both an 
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increase in pro-adipogenic gene expression and a decrease in anti-adipogenic gene 
expression are necessary for successful adipogenesis. 
While the regulation of adipogenesis from pre-adipocyte to mature adipocyte is 
well established, little is known about the early molecular events defining pre-adipocyte 
development. The Friedman group (Rodeheffer et al., 2008) identified potential adipocyte 
progenitor cells by using fluorescence-activated cell sorting (F ACS) to examine the SVF 
from W AT. They sorted the isolated SVF cells based on previously known stem cell 
markers and identified both a CD24+ and a CD24- subpopulation of early adipocyte 
progenitor cells that, with addition of an adipogenic cocktail, could differentiate in vitro 
into mature adipocytes. To detennine if CD24+ and/or CD24- cells could differentiate in 
vivo, the Friedman group injected the cells into A-Zip lipodystrophic mice. A-Zip 
lipodystrophic mice lack W AT as they contain a dominant negative protein (A-Zip/F), 
which interferes with the C/EBPa transcription, thereby preventing adipocyte 
differentiation (Moitra, 1998). After injection, it was the CD24+ population that led to 
development of fat depots that showed nonnal morphology and function, suggesting 
CD24+ cells may be a source of white adipocyte precursors. 
1.5 Cluster Of Differentiation 24 (CD24) 
CD24 is a heavily glycosylated glycosylphosphatidylinositol (GPI) linked cell 
surface receptor found on a variety of cells types including cancer cells, precursor B-cells, 
neurons, epithelia cells, macrophages and pre-adipocytes, among others (Fang and Zhen, 
201 0). It is expressed highly on progenitor cells and to a lesser extent on terminally 
differentiated cells. CD24 expression can direct cell survival in a cell type dependent 
manner. It is overexpressed in many types of cancers, causing cancer cell growth, 
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proliferation and metastasis (Agrawal et al., 2007; Huang and Hsu, 1997; Sagiv et al., 
2002), while it induces apoptosis in precursor B cells (Hough et al. , 1996; Suzuki et al. , 
2001). The molecular role ofCD24 in adipogenesis is not known. 
CD24 mRNA levels can be controlled at the transcription level downstream of 
phospholipase C-P 1 in erythroleukemia cells (Fiume, 2005), the RaJ GTPase in bladder 
cancer cells (Smith, 2006) and the dysregulated Hedgehog signalling in breast cancer cells 
(Cao, 20 12). The transcription factor nuclear factor of activated T -cells 5 (NF AT5) can 
upregulate CD24 expression in T lymphocytes by inhibiting hypennethylation of H3K27 
(lysine 27 of histone 3) (Berga-Bolanos, 20 I 0), while the estrogen receptor can 
downregulate CD24 in breast cancer cells by chromatin remodelling via histone 
deacetylase (Kaipparettu, 2008). In addition, the transcription factor Twist can repress 
CD24 expression in breast cancer cells by binding to the CD24 promoter, and thereby 
downregulating its expression (Vesuna, 2009). Twist is a transcription factor involved 
with cell lineage detennination and differentiation, and when overexpressed in 
mesenchymal stem cells (MSC), the MSC display a decreased capacity for 
osteo/chondrogenic differentiation and an enhanced capacity to undergo adipogenesis 
(Cakouros et al. , 20 10). Furthem1ore, both NFA T5 (also known as TonEBP) (Ferraris, J. , 
2004) and Twist (Firulli , A., 2008) can be activated by PKA, a mediator in 3T3-Ll 
adipocyte differentiation. 
CD24 mRNA levels can also be regulated by mRNA stability. CD24 mRNA is 
composed of a short 0.23 kb open reading frame and a long 1.3 kb 3 ' untranslated region 
(3 ' UTR). Zhou et al. (Zhou et al. , 1998) demonstrated that CD24 mRNA stability could 
be regulated by both positive and negative cis elements in the 3 'UTR, which modulate 
CD24 mRNA degradation. 
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The factor(s) that regulate CD24 expression in adipocytes are not known. 
Identification of CD24 regulators could make it possible to regulate CD24 expression in a 
tissue-specific manner and therefore, regulate cell survival and/or differentiation. 
1.6 Hypothesis and Objectives of Thesis 
Deciphering the early molecular events in adipogenesis is essential for fully 
understanding the process of adipogenesis and for the possible development of 
therapeutics. The purpose of this thesis was to examine the role of CD24 in adipogenesis 
using both in vitro and in vivo approaches. My major hypothesis is that 
CD24 directly regulates adipogenesis. To address this hypothesis, my objectives were: 
1. Detennine the CD24 mRNA and protein expression levels over the course of adipocyte 
development in vitro using the 3T3-Ll pre-adipocyte cell line. 
2. Identify the intracellular mediators regulating CD24 expression in vitro. 
3. Detennine the CD24 mRNA and protein expression levels in C57BL/6 mice fed a high 
fat diet compared to those fed a low fat diet. 
4. Detennine if activation of CD24 signalling, by antibody mediated clustering, is 
sufficient to affect adipogenesis in vitro and in vivo. 
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2.0 Materials and Methods 
2.1 Antibodies 
The antibodies (Abs) specific for CD24 (HIS50) and secondary Ab were 
purchased from Santa Cruz Biotechnologies (Santa Cruz, CA). The Ab specific for actin 
was purchased from Sigma (St. Louis, MO). 
2.2 3T3-Ll Adipogenesis assay 
All media and supplements were obtained from Life Technologies (Burlington, 
ON) unless otherwise indicated. 3T3-L1 cells (ATCC, Manassas, VA) were maintained in 
Dulbecco's Modified Eagle Medium supplemented with 10% newborn calf serum and 5% 
antibiotic/antimycotic (DMEM/NCS). 3T3-L1 cells were grown to confluency in 6-well 
(for protein analysis) or 12-well plates (for RNA analysis). To initiate adipogenesis, 48 
hours post-confluency, 0.5mM IBMX (Millipore, Billerica, MA) and 0.1 ~-tM DEX 
(Millipore) in DMEM supplemented with 10% fetal bovine serum and 5% 
antibiotic/antimycotic (DMEM/FBS) was added to the cells. 48 hours later, media was 
replaced with 10 ~-tg/ml insulin (Millipore) in DMEM/FBS. 48 hours later, media was 
replaced with progression media composed of only DMEM/FBS. Cells were maintained 
in this media for 5 days, replacing media every 2 days, until mature adipocytes were 
observed. Control cells were maintained in DMEM/NCS. Samples were taken 6 hours 
after addition ofiBMX and DEX, insulin and progression media in Trizol (Invitrogen, 
Carlsbad, CA), for mRNA analysis or radioimmunoprecipitation assay (RIPA) lysis 
buffer (RIPA: 50mM Tris-HCL, 0.02% sodium azide, 0.5% sodium deoxycholate, 0. 1% 
SDS, 1% NP-40, 150mM NaCl; plus inhibitors: 1 mM phenylmethanesulfonylfluoride, 
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1 mM sodium orthovanadate, I ug/ml aprotinin, I x HALT Phosphatase inhibitor 
(Thennoscientific) for protein analysis. 
2.2.1 Cycloheximide, actinomycin andforskolin treatment 
3T3-Ll cells were treated with 20flg/ml of cycloheximide (CHX) (Calbiochem) or 
I flg/ml of actinomycin-D (ACT) (Calbiochem) for 1 hour before addition ofiBMX and 
DEX. Cells were treated with forksolin (Calbiochem) or inactive forskolin (iForskolin; 
Calbiochem) at various concentrations (I Jlm, 2.5Jlm, 1 Oflm, 20J1m). Control samples were 
treated with equivalent volumes of dimethyl sulfoxide (DMSO) (Sigma-Aldrich). Six 
hours after treatment, samples were taken for mRNA analysis. 
2.2.2 CD24 antibody treatment 
CD24 antibody (HIS50) or nonnal mouse serum IgM was added to 3T3-Ll cells at 
various concentrations ( 400ng/ml, 800ng/ml, 1200ng/ml) along with IBMX/DEX and 
refreshed at every media change throughout the assay. Cells were maintained in this 
media for 5 days, until mature adipocytes were observed in the positive control well and 
then samples were taken for mRNA analysis. 
2.3 Animal diets and procedures 
2.3. 1 HFD experiment pe1jormed by Dr. Hirasawa in 2009 
The first HFD experiment was completed by Dr. Michriu Hirasawa, who donated 
a portion of the W AT from the epididymal fat depot. Male C57BL/6 mice (3 weeks old) 
(Charles River, Wilmington, MA) were fed a high fat diet (HFD) containing 45% energy 
from fat (Research Diets, Inc., New Brunswick, J 012451) or a low fat control diet 
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(LFD) containing 10% energy from fat (Research Diets, Inc. D 12450B) for a period of 0-
7 days. Mice were anethezised using halothane, sacrificed through cervical dislocation 
and the epididymal WAT was immediately frozen in liquid nitrogen for RNA extraction. 
2.3.2 HFD experiment pe1jormed by Christian lab in 2012 
Three-week-old C57BL/6 mice were fed a HFD ( 45% energy from fat) or LFD 
( l 0% energy from fat) for 1-7 days. Mice were anethezised using isoflurane, sacrificed 
through cervical dislocation and the epididymal W AT was immediately weighed and 
frozen in liquid nitrogen for RNA extraction or solubilized in RIPA buffer for protein 
analysis. 
2.3.3 Clustering ofCD24 by anti-CD24 antibody injection in vivo 
To induce clustering of CD24 in vivo, 3-week-old C57BL/6 male mice were 
injected intraperitoneally with 200!-tg of CD24 (M 1/69) functional grade antibody in 
200!-tl saline (lOmM NaH2P04+ 150mM NaCl), or 200!-tg of Rat IgG2b K isotype control 
( eB 149/1 OH5) in 200!-!1 saline, or 200!-tl of saline every 2 days, starting on day 0, over a 
period of 6 days. Mice were fed HFD ( 45% energy from fat) or LFD ( 10% energy from 
fat), starting on day 0. Mice were anesthetised using isoflurane, sacrificed by cervical 
dislocation and the epididymal W AT was immediately weighed and either frozen in liquid 
nitrogen for RNA extraction or fixed in 4% phosphate buffered paraformaldehyde for 
histology. 
All animal procedures were approved by Memorial University's Institutional 
Animal Care Committee. 
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2.6 RNA Isolation, Dnase Treatment and eDNA synthesis. 
All procedures were carried out according to the manufacturer's protocol. RNA 
was isolated using Trizol (Invitrogen), contaminating DNA removed with TURBO Dnase 
(Life Technologies) and eDNA synthesized from SOOng ofRNA using MMLV-RT 
(Invitrogen). 
2.7 Quantitative Reverse Transcriptase PCR (qRT-PCR) 
Fermentas Maxima SYBR Green qPCR Master Mix (2X) (ThermoScientific, 
Waltham, MA) was used to carry out Reverse transcriptase polymerase chain reaction 
(RT qPCR) using lOng of eDNA in an Eppendorf Mastercycler instrument. Sequence, 
efficiency and amplicon size of all primer sets can be found in Table 1. Ct values were 
analyzed after 40 cycles according to the Pfaffl equation, which is a modified version of 
/'-,./f.. cycle threshold (Ct) that takes into account the empirically determined efficiency of 
each primer set (Pfaffl, 2001 ). All primer sets have been validated and primer efficiencies 
detennined according to the MIQE guidelines (Bustin et al. , 2009). 
2.8 Western Blot 
Protein content was determined using the Bicinchoninic Acid (BCA) Protein 
Assay Reagent (ThennoScientific) according to the manufacturer's protocol and 20 J..tg of 
protein was run on a 10% SDS-PAGE gel. Antibodies were diluted in TBST+ 5% 
skim milk, CD24 (HIS50) 1:500, actin 1:2000, goat-anti-rabbit IgG 1:2000, and goat-anti-
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Table 1. qRT PCR primer sequences 
Gene Sequence Efficiency Amplicon Size 
CD24 F: 5 ' -ACT CAG GCC AGG AAA CGT CTC T-3 ' 1.07 109 
F: 5' -AAC AGC CAA TTC GAG GTG GAC-3 ' 
RPLPO F: 5' -TCA CTG TGC CAG CTC AGA AC-3' 1.03 101 
R: 5'-AAT TTC AAT GGT GCC TCT GG-3 ' 
GAPDH F: 5 ' -A TG TGT CCG TCG TGG A TC TGA-3 ' 1.00 164 
R: 5' -TGC CTG CTT CAC CAC CTT CTT-3' 
Pref- 1 F: 5' - CCC CCT TCG TGG TCC GCA AC-3' 1.0 I 182 
R: 5 ' -GGT GGG TCG CAT TCA GCC CC-3' 
CEBPa F: 5'-TGG ACA AGA ACA GCA ACG AG-3 ' 1.00 127 
R: 5'-TCA CTG GTC AAC TCC AGC AC-3' 
PPARy F: 5 ' -TGT TAT GGG TGA AAC TCT GGG-3' 1.00 145 
R: 5' -AGA GCT GAT TCC GAA GTT GG-3' 
Leptin F: 5 ' -ACC AGG CAC CCT TGG AGG GG-3 ' 1.05 78 
R: 5' -TGT GGG GCC CTC ACT CCC TG-3 ' 
Adiponectin F: 5 ' -GTT GCA AGC TCT CCT GTT CC-3' 1.00 192 
R: 5' -TCT CCA GGA GTG CCA TCT CT-3' 
Perilipin F: 5' -CTC GGT GTT ACA GGC AAG GA -3 ' 0.98 121 
R: 5'-TGT GCC CCT GGT CTC TCA T -3' 
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mouse IgM 1:2000. Immobilon Western Chemiluminescent HRP Substrate (Millipore) 
was used for signal detection. Images were acquired using an Alphaimager Gel 
Documentation system with FluorChem HD2 software, version 3.4.0. Image manipulation 
was limited to adjustments to brightness and contrast of the entire image. 
2.9 Histology 
W AT and liver samples were processed by the Histology Unit, Faculty of 
Medicine, Memorial University. Fixed WAT was paraffin embedded, sliced at 51Jm and 
stained with hematoxylin and eosin (H&E). Liver was frozen and stained with Oil Red 0 . 
Images were analyzed using ImageJ (Rasband, W.S. , U.S. National Institutes of Health, 
Bethesda, MA) and Cell Profiler (Carpenter et al. , 2006) and cell number detennined as 
previously described (Jo et al). Image manipulation was limited to adjustments to 
brightness and contrast of the entire image. 
2.10 Statistical Analysis 
Statistical analysis was performed using a one-way ANOV A if data were normally 
distributed when more than 2 samples were being compared, followed by a Tukey post 
hoc test, if significant, and using the Student' s t-test when only 2 samples were being 
compared. The data on cell surface area was not nonnally distributed; therefore a Kruskal-
Wallis test, followed by a Kolmogorov-Smimov post hoc test if significant, was 
perfonned. Differences were considered significant at p<0.05. Statistical analysis was 
detennined using Graphpad version 6.0 for Mac (GraphPad Software, La Jolla California 
USA) and VassarStats (Lowry R., 2010). 
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3.0 Results and Discussion 
3.1 CD24 mRNA and protein increase in vitro at initiation of adipogenesis 
To detem1ine if CD24 plays a role in adipogenesis, changes in CD24 gene 
expression, along with known adipogenic markers, were examined in the 3T3-Ll pre-
adipocyte cell line undergoing adipogenesis, by qRT-PCR and westem blot. IfCD24 
were involved in adipocyte differentiation, then changes in CD24 gene expression would 
be observed over the course of the adipogenesis assay. The adipogenic markers were 
chosen based on their known pattem of expression during 3T3-LI adipocyte development 
(Burton et al., 2004; Cao et al. , 20 12; Ntambi and Young-Cheul, 2000; Smas et al., 1998). 
Pref-1 is expressed on pre-adipocytes and is down-regulated on mature adipocytes (Smas, 
L 993). PPARy and CEBPa are major regulators of adipogenesis (Gregoire et al. , 1998) 
and are upregulated early in adipogenesis. Adiponectin is a marker of mature adipocytes 
(Lihn et al, 2005). 
As expected, Pref-1 mRNA expression decreased with adipocyte differentiation, 
while PPARy, CEBPa and adiponectin expression increased at the later stages (Fig. 2). 
CD24 expression significantly increased 6 h after addition of initiation media (IBMX and 
DEX) and then retumed to ini tial levels as the adipocytes matured (Fig. 2). 
To detennine if changes to CD24 mRNA expression correlate with changes to 
protein expression, CD24 protein expression was examined by westem blot. Simi lar to the 
changes in mRNA expression, CD24 protein levels increased 6 hours after initiation of 
adipogenesis with IBMX and DEX, and remained high 24 hours later, followed by a 
retum to baseline as the adipocyte matured (Fig.3). 
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Fig. 2. Initiation of adipogenesis with addition of IBMX and DEX increased 
CD24 mRNA expression in 3T3-Ll pre-adipocytes. mRNA expression of CD24 and 
known adipogenic markers in the 3T3-L I cell line was detennined throughout the 
various stages of the adipogenesis assay by qRT PCR. Proliferation: proliferating pre-
adipocytes; Confluent: cells are 100% confluent; Initiation: 6 hours after addition of 
dexamethasone and IBMX; Progression : 6 hours after addition of insulin; Maturity: 5 
days after addition of insulin, lipid fi lled adipocyte. Expression levels were 
nonnalized to the internal control RPLPO using the Pffafl equation (Pfaftl , 200 I) and 
calculated re lative to levels in proliferating cells. Data shown as mean ± SE. 
Expression changes in adiponectin were very large, therefore data for adiponectin is 
shown as log2 transformed. Statistical significance was detennined using one-way 
ANOVA, Tukey post hoc, n=3-4, different lower case letters indicate a significant 
difference of p<0.05 between groups. 
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Fig. 3. Initiation of adipogenesis with addition of IBMX and DEX increased 
CD24 protein expression in 3T3-Ll pre-adipocytes. Protein expression of CD24 
in the 3T3-Ll cell line during the various stages of the adipogenesis assay was 
detennined by western blot analysis. Confluent: cells are I 00% confluent; Initiation : 
6 hours after addition ofiBMX and DEX; 24 hour: 24 hours after DEX and IBMX 
addition; Progression: 6 hours after addition of insulin; Maturity: 5 days after 
addition of insulin, lipid fi lled adipocyte. Actin is used a loading control. A 
representative of 3 experiments is shown. 
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The expression pattern of the adipogenic genes Pref-1 , CEBPa and adiponectin 
that was observed throughout 3T3-Ll adipocyte development was expected and similar to 
that of previous studies (Burton et al. , 2004; Cao et al., 2012; Ntambi and Young- Cheul, 
2000; Smas et al. , 1998). There was significant decrease in Pref-1 mRN A expression and 
a significant increase in PPARy, CEBPa and adiponectin mRNA expression as the 
adipocytes matured. The increase in CD24 expression was observed earlier than the 
increase in PPARy, CEBPa and adiponectin suggesting that CD24 functions during the 
initial stages of adipogenesis. Furthennore, the return of CD24 to baseline level 
expression suggests that down-regulation of CD24 may be necessary for full 
differentiation. 
3.2 cAMP is sufficient to regulate CD24 mRNA expression in response to 
adipogenic media 
To begin to elucidate the signalling pathway that regulates CD24 mRNA 
expression levels in response to IBMX and DEX, the contribution of each individual 
component of the adipogenic media in regulating the increase in CD24 expression was 
examined. Confluent 3T3-L I cells were treated with IBMX, DEX or both IBMX and 
DEX for 6 hours, which is when the increase in CD24 mRNA was observed, and CD24 
mRNA expression was detennined by qRT-PCR. While treatment with IBMX or DEX 
significantly increased CD24 expression compared to confluent cells, it was the 
combination of both that caused the highest increase in expression, suggesting that IBMX 
and DEX function additively to regulate CD24 mRNA levels (Fig.4a). 
IBMX is a cyclic nucleotide phosphodiesterase inhibitor that can also stimulate 
adenylyl cyclase activity, resulting in increased cAMP levels (Parsons et al. , 1988). DEX 
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Fig. 4. A. IBMX and DEX act additively to increase CD24 expression while B. 
Forksolin increased CD24 mRNA expression in 3T3-Ll pre-adipocytes. a. 3T3-Ll 
cells were treated with DEX, IBMX or IBMX and DEX for 6 hours and mRNA 
expression ofCD24 was determined by qRT PCR. b. 3T3-Ll cells treated with Forskolin 
at the concentrations indicated and CD24 mRNA expression was determined by qRT PCR. 
Ratio ofCD24 expression in Forskolin treatment vs inactive Foskolin (iForskolin) was 
calculated. CD24 expression levels were normalized to the internal control RPLPO using 
the Pffafl equation and calculated relative to levels in a. untreated confluent cells b. 
DMSO-treated cells. Data shown as mean ± SE. Statistical significance detennined using 
one-way ANOVA, Tukey post hoc, n=4, different lower case letters indicate a significant 
difference of p<0.05 
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is a glucocorticoid that activates the glucocorticoid receptor, and can also act to increase 
cAMP levels by decreasing expression of cAMP-phosphodiesterase (Ahlstrom et al. , 
2005).transcription factors involved in adipogenesis (Elks and Manganiello, 1985). DEX 
has also been shown to inhibit cAMP phosphodiesterase expression, further increasing 
cAMP levels (Ahlstrom M, 2005). To detennine if an increase in cAMP is sufficient to 
regulate CD24 mRNA expression, 3T3-L I cells were treated with forsko lin, its inactive 
fonn (1 ,9-dideoxy-forskolin) or DMSO alone, as both forskolin and its inactive fonn were 
solubilized in DMSO. Forskolin is an activator ofadenylate cyclase (de Souza et al., 
1983), which increases cAMP levels. Treatment with forskolin increased CD24 mRNA in 
a dose-dependent manner, while inactiave forskolin had no affect on CD24 mRNA 
expression. Therefore this indicates that an increase in cAMP is sufficient to regulate 
CD24 expression in pre-adipocytes (Fig. 4b). 
The regulation of CD24 by cAMP has never before been demonstrated and 
provides a clear explanation for the previously observed discrepancy in the abili ty of 
CD24- cells to undergo adipogenesis in vivo compared to in vitro (Rodeheffer et al. , 
2008). As shown here, addition of supraphysiological levels of IBMX and DEX, increases 
the expression level of CD24 in vitro (Figs. I and 2). Therefore, it is reasonable to 
propose that CD24 expression was induced in cells that were originally identified as 
CD24- in response to ini tiation of adipogenesis in vitro, which would have resulted in 
sufficient CD24 expression to allow normal adipogenesis to occurs. Future experiments 
determining the abi lity of cells expression low leve ls of CD24 expression to increase 
expression in response to supraphysiologicallevels ofiBMX and DEX are necessary to 
definitively answer this outstanding question. 
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3.3 The increase in CD24 mRNA in response to IBMX and DEX is dependent on 
transcription and not mRNA stability. 
CD24 mRNA levels can be regulated at the level of transcription (Vesuna et al., 
2009; Wenger et al. , 1993) or by mRNA stability (Zhou et al., 1998). To detennine if 
CD24 mRNA is regulated by transcription, 3T3-Ll cells were treated with actinomycin-D 
(ACT), a transcription inhibitor (Sobell, 1985), for 1 h followed by IBMX/DEX for 6 h. 
If the increase in CD24 expression was inhibited with ACT pre-treatment then that would 
suggest that the increase in CD24 was dependent on transcription. Results showed that 
treatment with ACT inhibited the increase in CD24 expression stimulated with addition of 
IBMX/DEX, demonstrating that active transcription is necessary for the increase in CD24 
mRNA expression in 3T3-L1 cells (Fig. Sa). 
To detennine ifCD24 mRNA expression was regulated through de novo protein 
synthesis of a regulatory protein, 3T3-L1 cells were pre-treated with cycloheximide for lh 
followed by IBMX/DEX for 6h. Cycloheximide inhibits translational elongation, 
therefore blocking all de novo protein synthesis (Schneider-Poetsch, 201 0). If blocking 
protein synthesis by treatment with CHX prevented the increase in CD24 mRNA 
expression observed after IBMX and DEX treatment, then CD24 mRNA levels are likely 
regulated by de novo expression of a protein regulator, most likely a transcription factor. 
Conversely, if the increase in CD24 mRNA expression is not blocked by CHX pre-
treatment, then the protein regulator must be pre-existing. A significant increase in CD24 
mRNA was observed with the pre-treatment ofCHX followed by IBMX and Dex 
treatment. This increase was to the same level as IBMX and Dex only treatment, 
demonstrating that the increase in CD24 mRNA expression does not require de novo 
protein synthesis (Fig. 5b ). 
30 
a. 
12 b 
g 10 
!/) 
!/) 8 Q) 
I.. 
a. 
>< 6 w 
Q) 
4 > 
:;; 
<a 
a 
a 
Q) 2 a 
~ 
0 
so ()~ 
~() 
(;-
~ 
b. Treatment 
b b 
14 
c: 12 
0 
!/) 10 !/) 
Q) 
I.. 8 a. 
>< 
w 6 Q) 
> 
:;; 4 
<a 
Q) 2 a ~ 
a 
Treatment 
Fig 5. A. Blocking transcription with actinomycin-D inhibited the increase in 
CD24 expression seen with IBMX and DEX addition in 3T3-Ll pre-adipocytes, 
while B. blocking protein synthesis with cyclohexamide had no significant effect 
on CD24 expression. a. 3T3-Ll cells were treated with actinomycin-0 (act) for 1 h to 
inhibit transcription, fo llowed by IBMX and DEX. Six hours after addition oflBMX 
and DEX, mRNA expression of CD24 was determined by qRT PCR. b. 3T3-L l cells 
treated with cyclohexamide (CHX) for 1 h to inhibit de novo protein synthesis, 
followed by IBMX and DEX. Six hours after addition of IBMX and DEX, mRNA 
expression of CD24 was determined by qRT PCR. CD24 expression levels were 
normalized to the internal control RPLPO using the Pffafl equation and calculated 
relative to levels in cells treated with DMSO. Data are shown as mean ± SE. 
Statistical significance was determined using one-way ANOVA, Tukey post hoc, n=4, 
different lower case letters indicate a significant difference of p<0.05 between groups. 
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CHX treatment alone also increased CD24 mRNA expression. Increased mRNA 
expression of early and primary response genes has been reported with CHX treatment, as 
well as with other protein biosynthesis inhibitors, through a process called superinduction 
(Hershko et al., 2004; Okazaki Ret al. , 1992; Newton et al. , 1996). Superinduction is 
poorly understood, but it is thought to be regulated by decreased mRNA degradation 
(Hershko et al..,2004). Although there is an increase in CD24 mRNA with CHX 
treatment, it is not to the same level as treatment with CHX followed by IBMX and DEX. 
Moreover, there was no reduction in CD24 mRNA in the presence of CHX compared to 
IBMX and Dex alone. Therefore, the mediator regulating CD24 expression in response to 
IBMX and DEX is not affected by inhibiting protein synthesis, and hence must be pre-
existing. 
3.4 Antibody mediated clustering of CD24 decreases adipogenesis in 3T3-Ll cells 
Previous work has shown that both CD24+ and CD24- primary pre-adipocytes can 
undergo adipogenesis in vitro, while only CD24+ cells can develop into functional W AT 
depots in vivo (Rodeheffer et al., 2008). This suggests that the expression level of CD24 
may not directly regulate adipocyte differentiation, but that activation of downstream 
signalling in response to ligand binding may be more important. Addition of anti-CD24 
Ab to crosslink and cluster CD24 has been shown in cancer cell lines (Kim et al. , 2008) 
and B cell lines to induce activation (Suzuki et al. , 200 1) of signal transduction pathways 
downstream of CD24. Therefore, in an attempt to mimic ligand binding of CD24 at the 
cell surface, 3T3-LI cells were treated with anti-CD24 Ab (RISSO) or the isotype control 
(normal mouse IgM) starting at the initiation stage, which is the stage when the increase 
in CD24 expression levels was observed (Figs. 2 and 3). The isotype control has no 
32 
specificity for CD24, but retains all the non-specific characteristics of the CD24 A b. It 
was used to con finn the specificity of the CD24 Ab binding, as well as to rule out non-
specific Fe receptor binding or other non-specific interactions. This experiment would 
detennine if clustering of CD24 by addition of anti-CD24 Ab was sufficient to affect 
adipogenesis. Samples were taken at the end of the assay, when it was visually confonned 
that lipid filled adipocytes had fonned in the positive control wells not treated with Ab, 
and the mRNA levels ofthe pro-adipogenic genes, C/EBPa, PPAR-y and adiponectin, 
were examined using qRT-PCR to determine the effect on adipogenesis. 
With addition of increasing concentrations of anti-CD24 Ab, C/EBPa and 
adiponectin expression decreased in a dose-dependent manner (Fig. 6). While there was 
no significant change in PPAR-y, there was a decreasing trend in expression with 
increasing Ab concentration. In addition, the accumulation of lipid droplets was visually 
assessed and was found to decrease with increasing concentration of anti-CD24 antibody 
treatment, compared to the isotype control (data not shown). Interestingly, with increasing 
concentrations of anti-CD24 Ab, CD24 mRNA expression also increased suggesting that 
Ab-mediated clustering of CD24 can positively regulate CD24 mRNA expression. 
Increasing CD24 mRNA expression correlated with decreased levels of C/EBPa, 
adiponectin and PPAR-y, suggesting that CD24 expression is inversely correlated with 
known markers of adipogenesis. There were no significant changes in gene expression in 
the isotype control samples (Fig. 6). 
It is important to note that there is no assay for CD24 activation and it is unknown 
what happens to the CD24 protein when it is bound by Ab. It is possible that binding of 
the Ab may actually block CD24 expression by down regulating the receptor expression 
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Fig. 6. Increased CD24 expression resulted in decreased mRNA expression of late 
adipogenic genes. CD24 Ab (HIS50) or isotype control (normal mouse serum IgM) 
was added to 3T3-L1 cells, along with IBMX/Dex and refreshed at every media 
change throughout the assay. Cells were sampled when mature adipocytes developed 
in the positive sample and mRNA expression was detennined by qRT-PCR. Neg: 
confluent, non-treated cells; Pos: cells treated with IBMX/Dex; Iso: cells treated with 
isotype control; Ab: cells treated with CD24 antibody. The mRNA expression levels 
are shown for CD24, adiponectin, CEBPa and PPARy. Expression levels were 
normalized to RPLPO using the Pffafl equation and calculated relative to levels in 
confluent cells. Data is shown as mean ± SE. Statistical significance was determined 
using a Student t-test between cells treated with isotype and antibody of the same 
concentration, or neg and pos, n=3, *p<O.Ol , **p<0.05 
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through internalization, as in the case of other GPI-linked proteins (Deckert et al., 1996). 
To detennine if addition of anti-CD24 Ab is causing internalization of CD24, CD24 could 
be tagged with a fluorescently labelled probe and internalization followed by confocal 
microscopy. 
To detennine if increased expression of CD24 throughout adipogenesis inhibits 
adipogenesis, CD24 should be constitutively over-expressed in the 3T3-L1 cell line and 
adipogenic outcome measured by changes in mRNA expression of adipogenic markers, as 
well as Oil Red 0 staining of neutral lipid accumulation. However, the 3T3-Ll cell line is 
a very difficult cell line to transfect, and after many unsuccessful attempts, Ab-mediated 
clustering of the CD24 Ab was used as a way to cluster endogenously expressed CD24 
and activate intracellular signalling. To determine if Ab-mediated clustering of CD24 is 
activating intracellular signalling in 3T3-L 1 cells as demonstrated in several other cells 
lines, activation levels of the mitogen-activated protein kinases ERK 112, Lyn, a member 
of the Src family of proteins, and p38, all downstream of CD24, should be detennined 
(Sammar et al. , 1997; Suet al. , 2012; Suzuki et al. , 2001) 
Genes associated with later stages of adipogenesis (PPAR-y and C/EBPa) and 
mature adipocyte function (adiponectin) were measured as a quantitative indication of 
adipogenesis. A difference in expression of these genes between anti-CD24 Ab treated 
cells and isotype control cells suggested an effect on adipogenesis. While there was 
decreased expression of PPARy, it was not significant. Therefore, a better indication of 
overall adipogenesis is needed. Analyzing more adipogenic markers such as the glucose 
transporter (GLUT4) which markedly increases in mature adipocytes, as well as markers 
involved in triglyceride synthesis and lipogenesis such as acetyl-CoA carboxylase (ACC), 
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stearoyl-CoA desaturase (SCD l ), and fatty acid synthase (Spiegelman et al. , 1983; 
Weiner et al. , 1991; Garcia de Herreros and Bimbaum,1989), would allow for a more 
global gene analysis and thus a better indication of adipogenesis. Alternatively, global 
gene expression analysis by DNA microarray would give a complete view of the response 
of the entire genome. 
While lipid accumulation was visibly decreased in response to Ab-mediated 
clustering, this was not imaged by Oil Red 0 staining, which is a qualitative measure of 
neutral lipid accumulation. Future experiments will include imaging of the cells after Oil 
Red 0 staining to verify overall changes to adipogenesis. 
Even though the mechanism for regulation of adipogenesis by CD24 remains 
unclear, there is a clear inverse correlation of CD24 gene expression and mature 
adipogenic gene expression. As CD24 expression increased in the adipocyte, the late 
stage markers of adipogenesis C/EBPa and adiponectin decreased. This suggests that 
CD24 expression must decrease to allow adipogenesis to occur, supporting the hypothesis 
that an increase in CD24 expression at an early stage in adipogenesis, followed by its 
downregulation, is necessary for full differentiation and/or mature adipocyte function . 
3.5 High fat diet increases CD24 mRNA expression in WAT at an early time point 
during adipogenesis 
Addition of the initiation media (IBMX and DEX), promoting adipogenesis, was 
found to increase CD24 expression in 3T3-L 1 pre-adipocytes, suggesting that regulation 
of CD24 expression contributes to adipogenesis in vitro. To detennine if CD24 expression 
is regulated during adipogenesis in vivo, in a similar manner to what was found in vitro, 
expression of CD24, along with the other adipogenic genes, was examined in 3 week-old 
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mice fed a high fat diet (HFD, 45% of energy from fat) or a control low fat diet (LFD, 
10% of energy from fat) for 0 to 7 days. 
After 1 week of feeding, there was no significant difference in caloric intake or 
body weight between diets (Fig. 7). As only a portion of the fat depot was sampled in this 
donated tissue, W AT mass was not recorded. After 2 days of feeding, mice fed a HFD had 
significantly higher Pref-1 and CD24 mRNA expression levels compared to mice fed a 
LFD (Fig. 8). The increase in CD24 expression decreased by day 7, however it remained 
significantly higher than the LFD group. No other changes in adipogenic gene expression 
were observed suggesting that adipogenesis is at its initial stages. The increase in CD24 
expression is observed concurrently with an increase in the pre-adipocyte marker Pref-1 
and before an increase in any later markers of adipogenesis, suggesting that a HFD can 
increase CD24 expression at a very early time point during adipogenesis in vivo. 
There are several studies examining changes in adipocyte gene expression during 
diet induced obesity in rodents, however these studies examine much longer feeding 
periods (2-18 weeks) and with older mice (6-8 weeks old). There are very few studies that 
have looked at gene expression during a short tenn HFD feeding in young (3 week old) 
mice. It is known though that within 1 week of a HFD, mice have increased epididymal 
fat mass and increased adipocyte size compared to mice fed a LFD (Lee et a!., 20 11 ; 
Winzell and Ahren, 2004). From birth until 3-4 week of age, adipose tissue growth in 
rodents is hyperplastic and overfeeding during this period can result in permanent weight 
gain and increased fat cell number. From 4-14 weeks, adipose tissue growth occurs 
through both hypertrophy and hyperplasia, and after 14 weeks, adipose tissue grows 
primarily by hypertrophy (Jo et al. , 2009; Li et al. , 2002). Further, mice fed a HFD for 1 
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Fig. 7. No difference in body weight or caloric intake was observed in mice fed a 
LFD or HFD for one week. Three-week-old C57BL/6 mice were fed a 10% energy 
from fat low-fat diet (LFD) or 45% energy from fat high-fat diet (HFD) for 1 week. This 
experiment was part of a larger experiment completed by Dr. Michiru Hirasawa. a. 
Body weight in grams b. Calorie intake in kCal/day. Data is shown as mean ± SE. 
Calorie intake was measured per group, not per mouse, therefore no standard deviation 
was calculated . Statistical significance was detennined using a Student t-test, n=5-7 
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Fig. 8. CD24 and Pref-1 mRNA expression increased in WAT of mice after 2 days of 
HFD. Three-week-old C57BL/6 mice were fed a low fat diet (LFD, 10% energy from 
fat) or a high fat diet (HFD, 45% energy from fat) for up to 1 week. mRNA was isolated 
from the epididymal white adipose tissue at days 1, 2 and 7, and gene expression analysis 
conducted by RT-qPCR. Expression levels were normalized to RPLyoutube.com 
PO using the Pffafl equation and calculated relative to one LFD control mouse. Data 
shown as mean ± SE. Statistical significance was detennined using a Student t-test, n=5-
7, *p<O.Ol , **p<0.05 
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week exhibit increased plasma glucose and insulin levels (Marques et al. , 2000; Winzell 
and Ahren,2004). This data suggests that within 1 week of a HFD, mice are on the path to 
obesity and adipogenesis is likely initiated. Because the mice in this study are less than 4 
weeks of age, the changes to adipose tissue growth is most likely due to hyperplasia, 
although there may be hypertrophic effects as well (Jo et al. , 2009; Li et al. , 2002). 
3.6 High Fat Diet increases mRNA expression of late adipogenic markers but no 
effect on CD24 mRNA expression 
To examine both mRNA and protein expression levels of CD24 in W AT, the HFD 
vs LFD feeding study was repeated. Expression levels of CD24 and the known adipogenic 
genes were detennined by qRT-PCR, while CD24 protein expression levels was 
determined by western blot analysis. There was no significant difference in food intake or 
overall body weight between mice fed LFD or HFD, however mice on a HFD had 
significantly greater W AT mass after only 1 day of feeding (Fig. 9). 
Unexpectedly, the increase in neither Pref- 1 nor CD24 mRNA expression in 
response to a HFD was not observed. However, there was a significant increase in mRNA 
levels of PPARy, Leptin and Adiponectin after 1 day of a HFD (Fig. 10) indicating a very 
rapid induction of adipogenesis by the HFD. Analysis of protein expression by western 
blot found no significant difference in CD24 protein levels (Fig. 11 ). The densitometry 
analysis does however suggest a possible trend for increased CD24 protein expression 
after 2 days ofHFD (Fig. 11e). The increase in PPARy, Leptin and adiponectin mRNA 
expression after 1 day of HFD suggests that the HFD is inducing adipogenesis very 
rapidly and in a different time frame than the first HFD experiment and therefore the 
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Fig. 9. Mice fed a HFD had significantly more WAT but not body weight after one day 
of HFD. Three-week-old C57BL/6 mice were fed a low fat diet (LFD, 10% energy from 
fat) or a high fat diet (HFD, 45% energy from fat) starting at 3 weeks of age for up to one 
week. a. Calorie intake in kCal/day b. Body weight in grams and c. WAT weight in grams. 
Data in b. and c. shown as mean ± SE. Statistical significance was determined using a 
Student t-test, n=8, *p<O.O l , **p<O.OS 
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Fig. 10. No change in CD24 or Pref-1 mRNA expression with HFD but a significant 
increase in expression of late adipogenic markers with HFD was observed. mRNA 
expression in WAT of3-week-old C57BL/6 mice fed a low fat diet (LFD, 10% energy from 
fat) or a high fat diet (HFD, 45% energy from fat) for up to one week, as detennined by qRT 
PCR. Expression levels were nonnalized to RPLPO using the Pffafl equation and calculated 
relative to one LFD control mouse. Data shown as mean ± SE. Statistical significance was 
determined using a Student t-test, n=8, *p<O.O l , **p<0.05 
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Fig. 11. No significant d ifference in CD24 protein expression was observed in mice fed a 
HFD or LFD. Representation of protein expression of CD24 in C57BL/6 mice fed a low fat diet 
(LFD, 10% energy from fat) or a high fat diet (HFD, 45% energy from fat) starting at 3 weeks 
old after a. 1 day, b. 2 days, c. 4 days or d. 7 days of feeding. Densitometry analysis of 
CD24/ Actin is displayed in e. Data shown as mean ± SE. Actin was used as a loading control, 
showing western blot for half of each diet group, n=8 
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increase in CD24 expression may have been missed. Again, there are no other studies 
examining gene expression of these common adipogenic markers during a short tenn 
HFD. This is the first time such a rapid increase in PPARy, Leptin and adiponectin 
mRNA expression in response to a HFD has been shown. 
Although diet induced obesity in mice is commonly used to study adipogenesis, 
there are often differences in response to the HFD between strains, age and sex of the 
mice (see section 1.2.1.1). Different responses to a HFD have even been found between 
C57BL/6 mice within the same litter, which may account for some variability between 
experiments (Koza et a!. , 2006). 
Differences in the procedures used to obtain the W AT may also account for the 
different results. The first HFD experiment was completed by Dr. Michiru Hirasawa, who 
donated the W AT for our analysis. Halothane was used to anaesthetize the mice, while in 
the second HFD experiment isoflurane was used. While all volatile anaesthetic agents will 
produce a drop in blood pressure, the effects are mediated in different ways. While 
halothane produces a direct depression on myocardial function causing hypotension, 
isoflurane contributes to hypotension through peripheral vasodilation (Gelman eta!. , 
1984). Pre-adipocytes have been found to be located in the vasculature (Cawthorn eta!., 
2011 ). By using isoflurane, the vasculature in the W AT may have been altered, which 
could be hypothesized to change the localization of pre-adipocytes in the W AT, however 
there are no studies demonstrating the effects of isoflurane on pre-adipocyte localization. 
Furthennore, when removing the adipose tissue, we were careful not to include any of the 
gonadal tissue located next to the W AT and to avoid vasculature within the W AT. 
Therefore by removing the vasculature, we may also have lost a population of pre-
adipocytes which could explain why there was no change in Pref-1 mRNA expression. 
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The 3T3-Ll experiments suggest that CD24 expression is regulated specifically on pre-
adipocytes, therefore, a loss of pre-adipocytes, as suggested by the lack of change in Pref-
1 expression would also result in no observable changes to CD24 expression. 
3. 7 Serial injections of anti-CD24 antibody reduced W AT and overall body weight of 
mice fed HFD 
Antibody mediated clustering ofCD24 in 3T3-L1 cells resulted in decreased 
expression of adipogenic markers. To determine if clustering of CD24 by anti-CD24 Ab 
injection would have an effect on adipogenesis in vivo, 3-week-old mice were injected 
with a monoclonal anti-CD24 Ab or saline every 2 days over the course of I week. Like 
the 3T3-Ll Ab experiment (Section 3.4), this was a pilot experiment to detennine if 
clustering of CD24 by anti-CD24 Ab injection would have any effect on adipogenesis in 
mice fed a HFD. Again, it is important to note that it is unknown if CD24 is being 
activated or possibly blocked with anti-CD24 injection, and although anti-CD24 antibody 
was injected directly into the inter-peritoneal region, CD24 is expressed on many different 
cell types and therefore the response could be non-specific to adipocytes. 
Saline injected mice were fed either a LFD or HFD while the group of mice 
injected with anti-CD24 were fed a HFD. A second set of mice were injected with a 
control Ab of the same isotype as the anti-CD24 Ab (rat IgG2a) or saline and fed a HFD. 
All mice were introduced to the experimental diets on the same day as the first injection. 
Mice injected with anti-CD24 antibody weighed significantly less, had 
significantly less caloric intake per day and had significantly less W AT mass compared to 
mice injected with saline (Fig 12). Mice injected with saline and fed a HFD had 
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Fig. 12. M ice injected with anti-CD24 antibody consumed significantly less calories, 
weighed less a nd had less WAT then mice injected with saline. Three-week-old C57BL/6 
mice were fed a low fat diet (LFD, 10% energy from fat) or a high fat diet (HFD, 45% energy 
from fat) for one week. Every 2 days, starting on day 0, mice were injected intra-peritoneally 
with 200!-tg, in 200!!1, of anti-CD24 antibody (M l/69) or 200!!1 saline, for a total for 4 
injections. a. Calorie intake in kCal/day b. Body weight in grams c. WAT mass on day 7 d . 
Dorsal view of mice, from left to right, LFD, HFD, HFD + CD24-Injected. Data for b . and c. 
shown as mean ± SE. Statistical significance was detennined using a One-way ANOVA 
followed by Tukey post-hoc, n=6. For a .* HFD vs HFD+anti-CD24 injection, p<0.01 on day 
4 and 5, p<0.05 on day 6. **LFD vs HFD+anti-CD24 injection, p<O.Ol. For b.* HFD vs 
HFD+anti-CD24 injection, p<0.05 on day 1, p<O.O 1 for all other significant days. ** LFD vs 
HFD+anti-CD24 injection, p<0.05 on day 3 and 4, p<0.01 on day 5 and 7. For c. p<O.Ol. n=6 
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Fig. 13. No significant d ifference was observed in calorie intake, body weight and 
WAT in mice injected with anti-CD24 isotype or saline. Three-week-old C57BL/6 
mice were fed a high fat diet (HFD, 45% energy from fat) and given an intra-peritoneal 
injection of 200 fAg anti-CD24 isotype control or saline following the injection 
schedule in Fig 15. a. Calorie intake in kCal/day b. Body weight in grams c. WAT 
weight in grams. Data shown as mean ± SE. Statistical significance was detennined 
using a Students t-test, n=3 
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a. b. 
c. d. 
Fig. 14. No difference in lipid accumulation was observed in the liver of mice 
injected with anti-CD24 antibody, anti-CD24 isotype control or saline. Liver 
histology samples were stained with Oil Red 0 to determine lipid accumulation. a. 
Low fat diet, saline injected, b. High fat diet, saline injected, c. High fat diet, anti-
CD24 antibody injected, d. High fat diet, isotype control antibody injected 
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Fig. 15. No significant diffe rence was observed in CD24 mRNA expression or 
other adipogenic gene expression in mice injected with anti-CD24 antibody or 
saline. mRNA expression of 3 week old mice fed either a low fat diet (LFD, 10% 
energy from fat) or a high fat diet (HFD, 45% energy from fat) and injected with 
saline or anti-CD24 antibody for 1 week, as determined by qRT PCR. Expression 
levels were nonnalized to RPLPO using the Pffafl equation and calculaied relative to 
one LFD control mouse. Data shown as mean ± SE. Statistical significance was 
detennined using a One-Way ANOVA, n=6 
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Fig. 16. No significant difference was observed in CD24 mRNA expression or 
other adipogenic gene expression in mice injected with anti-CD24 isotype or 
saline. mRNA expression of 3 week old mice fed either a low fat diet (LFD, 10% 
energy from fat) or a high fat diet (HFD, 45% energy from fat) and injected with 
saline or anti-CD24 isotype control for 1 week, as detennined by qRT PCR. 
Expression levels were normalized to RPLPO using the Pffafl equation and calculated 
relative to one LFD control mouse. Data shown as mean ± SE. Statistical significance 
was detennined using a student T -test, n=3 
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significantly more W AT than mice injected with saline and fed a LFD (Fig. 12). There 
was no significant difference in body weight, calorie intake or W AT mass in mice fed a 
HFD injected with saline and mice fed a HFD injected with anti-CD24 isotype control 
(Fig. 13). 
Because there was such a dramatic difference in W AT in mice injected with anti-
CD24 Ab compared to mice fed a HFD, the lipid accumulation in the liver was examined 
to determine if the reduced W AT size was leading to fat deposition in other tissues. There 
was no difference found in Oil Red 0 staining of lipid in liver histology sections from 
saline injected animals or anti-CD24 injected animals on HFD (Fig. 14). 
No significant difference in mRNA expression of CD24 or any of the adipogenic 
genes examined by qRT-PCR was found (Fig. 15, 16). In addition to the known 
adipogenic genes studied previously, the expression of perilipin, a protein that acts as a 
protective coating on lipid droplets in adipocytes (Brasaemle, 2007), was examined as an 
indicator of lipid droplet size. Similar to the other adipogenic genes, no changes in mRNA 
expression were observed (Fig. 15, 16). 
There was however a trend for an increase in CD24 mRNA expression (p=0.086) 
in mice injected with anti-CD24 Ab suggesting a possible positive feedback whereby 
clustering of anti-CD24 Abmay regulate CD24 expression itself, which is similar to the 
findings in the 3T3-L 1 cells (Fig. 6). 
To detennine the cause of the large difference in the W AT mass of the anti-CD24 
injected mice, the cell surface area of the adipocytes was examined to determine if anti-
CD24 injection affected cell size (hypertrophy) or cell number (hyperplasia) . Cell surface 
area of histology samples from the LFD, HFD and HFD + anti-CD24 injection, as well as 
the HFD and HFD + anti-CD24 isotype control groups, was detennined using Cel!Profiler 
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Fig. 17. A-C. Significant differences were observed in the distribution of cell 
surface area in WAT of mice fed a LFD, HFD and HFD + anti-CD24 antibody. D. 
No difference in adipocyte cell number between diets. Cell surface area of 3 week 
old mice fed either a low fat diet (LFD, 10% energy from fat) or a high fat diet (HFD, 
45% energy from fat) and injected with saline or anti-CD24 antibody for 1 week. 
Frequency distribution for a. low fat diet, b. high fat diet or c. high fat + anti-CD24 
injection is shown. Data shown as percentage of total cells analyzed. d. The number of 
cells in the WAT was calculated base on the adipocyte size distribution and fat depot 
mass using the previously described fonnula (Jo et al. , 2009). No significant 
difference was found . Data shown as mean ± SE and y-axis is log transfonned. 
Statistical significance was detennined using a Kruskal-Wallis test, followed by a 
Kruskal--Smimov post hoc, p<O.OOO 1 in a-c. Statistical significance was detennined 
using a One-way ANOVA in d. 
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Fig. 18. No significant difference was observed in the d istribution of cell surface 
area in WAT of mice fed a HFD + saline and HFD + anti-CD24 isotype control. 
Cell surface area of 3 week old mice fed a high fat diet (HFD, 45% energy from fat) 
and injected with either saline or anti-CD24 isotype control for 1 week. Frequency 
distribution for a . HFD + saline, b. HFD +anti-CD24 isotype control. Data shown as 
percentage of total cells analyzed. Statistical significance was determined using a 
Kruskal-Wallis test. 
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(Carpenter et al., 2006). To determine if anti-CD24 injection had an effect on 
hypertrophy, the resulting histograms of cell surface area were analyzed (Fig. 17). There 
was a significant difference in cell surface area distribution between the LFD, HFD and 
HFD + anti-CD24 injection groups. The greatest percentage of cells within the HFD 
groups had a surface area of less than I OOOJ..lm with a declining distribution through the 
larger sizes while the LFD group had the greatest percentage of cells between l OOOJ..lm 
and 2000J..lm and was much less distributed through the larger sizes. The greatest 
percentage of cells within the HFD + anti-CD24 injected mice had a surface area of less 
than l OOOJ..lm (34%) and between l 000-2000f..lm (34%) and was much less distributed 
through the larger sizes suggesting that anti-CD24 injection affected cell size. There was 
no significant difference found in the distribution of the HFD or HFD + anti-CD24 
isotype control groups (Fig. 18). 
To detennine if there was a hyperplasic effect, the total cell number, was 
determined using the mean cell size distribution and fat depot mass (Jo et al., 2009). 
Although there was an increase in number of cells in the anti-CD24 injection group, there 
was no significant difference in cell number between the LFD, HFD and HFD + anti-
CD24 injection groups, suggesting there was no change in hyperplasia (Fig. l 7d). 
Therefore the differences in fat depot mass in response to a short tenn HFD are most 
likely due to changes in cell size, where anti-CD24 injection resulted in smaller 
adipocytes. 
Adipose tissue can grow by both hyperplasia and hypertrophy. The resu lts showed 
a significant increase in W AT weight after I week of a HFD compared to the LFD, while 
there was a significant decrease in W AT after I week of a HFD + anti-CD24 injection 
compared to the LFD and HFD. There was a larger increase in cell size distribution in 
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mice fed a HFD compared to LFD, where mice fed a HFD had more large cells, while 
mice fed a HFD + anti-CD24 injection had significantly more smaller cells ( <2000~.tm) 
compared to both LFD and HFD. This suggests that a HFD is inducing hypertrophy, 
increasing cell size, while anti-CD24 injection is preventing hypertrophy. However, there 
were no changes in mRNA expression of any of the adipogenic genes tested. It is 
expected that with increasing cell size, leptin, adiponectin and perilipin expression would 
increase. As stated in section 3.4, future experiments should examine a larger variety of 
adipogenic genes such as GLUT 4, ACC, SCD 1 and fatty acid synthase, to obtain a more 
global gene analysis, allowing for a better indication of changes in adipogenesis. 
Like the previous in vivo experiment, isoflurane was used as the anaesthetic, 
which may have affected the results in a similar manner. Mice that were injected with 
anti-CD24 antibody were hypophagic, having significantly less calorie intake on days 4-6. 
Serum sickness is a common syndrome that occurs with antibody injection, due to the 
fonnation of Ab-Ab immune complexes in response to the foreign Ab (D'Arcy, 200 1). 
Hypophagia is a symptom of serum sickness, however because the anti-CD24 isotype 
control injected mice did not exhibit hypophagia, it is unlikely that the mice were 
experiencing serum sickness. Furthennore, CD24 is expressed on a variety of cell types 
and therefore any effects on adipogenesis may be due to secondary/indirect effects on 
other cell types. Mice injected with anti-CD24 antibody also had a severely enlarged 
spleen compared to the other groups (data not shown). The spleen consists of many cells 
that express CD24 such as T cells, B cells and dendritic cells. CD24 can act as a co-
stimulator, acting synergistically with B7, to cause the clonal expansion ofT cells (Liu et 
al. , 1992; Wang et al. , 1995), therefore the injected antibody may have been activating T 
cells in the spleen, rather then adipocytes, causing proliferation and growth of the T cell 
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population and enlarging the spleen. Such a large immune reaction may have resulted in 
sick mice, causing reduced appetite and therefore resulting in decreased adipose tissue 
development as a secondary effect. 
This experiment was completed with two different cohorts of mice whose physical 
response to the HFD was different. Mice fed a HFD in the second cohort did not gain as 
much weight as mice fed a HFD in the first cohort. They also had much less W AT on day 
7, having less W AT then both mice fed a LFD or HFD in the fi rst cohort. Again, it has 
been previously demonstrated that there can be differing responses to a HFD between and 
within strains of mice. Therefore, because there was such a drastic difference in response 
to a HFD between the mice cohorts, caution must be used when interpreting the results 
from this experiment. 
4.0 Conclusion and Future Directions 
This research is the first to show that CD24 expression can be regulated during 
adipogenesis. Upon initiation of adipogenesis, CD24 mRNA and protein levels increased 
in pre-adipocytes in vitro. This increase in CD24 expression is regulated by transcription, 
likely through activation of a pre-existing protein regulator such as a transcription factor. 
Increasing cAMP levels were found to be suffic ient to increase CD24 mRNA levels, 
demonstrating a role for cAMP as a primary intracellular mediator regulating CD24 
expression in pre-adipocytes in vitro (Fig. 19). 
To continue to elucidate the signalling pathway regulating CD24 mRNA 
expression levels in response to IBMX and DEX, the downstream target of cAMP should 
be detennined. The two major downstream targets of cAMP that are essential for 
adipogenesis are Protein Kinase A (PKA) (Taylor eta!. , 1990) and exchange proteins 
activated by cAMP (EPAC- 1, EPAC-2) (de Rooij et a!., 1998). Future work will 
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Fig 19. IBMX and DEX regulate CD24 mRNA expression by increasing cAMP 
resulting in transcription of the CD24 gene. Schematic diagram of the regulation of 
CD24 expression in 3T3-L 1 pre-adipocytes. IBMX and DEX increase cAMP, which can 
activate downstream mediators PKA and/or EPAC-1-2. Further downstream, IBMX and 
DEX result in transcription of the CD24 gene, likely by a pre-existing transcription factor 
(TF), resulting in increased CD24 mRNA and protein expression. Numbers represent 
future directions in elucidating this pathway; 1. to determine mediator directly downstream 
of cAMP 2. to determine the TF regulating CD24 expression 
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determine the downstream target of cAMP by treating 3T3-Ll cells with inhibitors 
specific for PKA or EPAC, followed by IBMX and DEX and measuring CD24 
expression. The increase in CD24 mRNA expression in 3T3-Ll cells in response to 
IBMX and DEX is dependent on transcription. There are several transcription factors that 
can regulate CD24 expression, including NF A TS , which upregulates CD24 expression in 
T -lymphocytes and Twist, which downregulates CD24 expression in breast cancer cells. 
Furthennore, overexpression of Twist in mesenchymal stem cells induces adipogenesis. 
Additionally, both NFATS (also known as TonEBP) (Ferraris, J. , 2004) and Twist (Firulli, 
A. , 2008) can be activated by PKA, a possible mediator ofCD24 expression in 3T3-Ll 
cells. Future work will include identification of the transcription factor regulating CD24 
mRNA expression in pre-adipocytes by promoter analysis and/or chromatin 
immunoprecipitation (ChiP) analysis. 
Increased CD24 expression was found to associate with decreased adipogenic 
gene expression. To determine if a loss of CD24 function affects adipogenesis, future 
work would include knocking out CD24 expression in 3T3-Ll s using siRNA and 
measuring adipogenesis by both mRNA expression of the adipogenic markers, as well as 
Oil Red 0 staining, to detem1ine if loss of CD24 abrogates the effect of antibody 
mediated CD24 expression. Conversely, to detennine if increased CD24 function affects 
adipogenesis, CD24 should be overexpressed in 3T3-L 1 cells and adipogenesis measured 
by both mRNA expression of the adipogenic markers, as well as Oil Red 0 staining. 
An increase in CD24 and Pref- 1 mRNA was observed after 2 days of a HFD 
suggesting an increase in the CD24 cell population at the initial stages of adipogenesis. 
However, when thi s study was replicated a second time with the same diet, an increase in 
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mRNA of the late adipogenic markers was observed after 1 day of a HFD, while no 
change in Pref-1 or CD24 expression was observed. Injection with the anti-CD24 Ab had 
no effect of gene expression, but there was a dramatic reduction in W AT in the anti-CD24 
antibody injected mice. 
To discern the role of CD24 in vivo, future studies would focus on culturing 
primary cells from the SVF of both mouse and human W AT and detennining expression 
of CD24 mRN A and protein during adipogenesis of primary cells. It is expected that 
CD24 would follow a similar pattern of expression as in the 3T3-Ll cells, where it 
increases expression at initiation of adipogenesis, then decreases to baseline as the 
adipocyte matured. 
It is unknown if CD24 is actually being activated with anti-CD24 Ab injection, or 
if the anti-CD24 Ab is interfering with ligand binding or perhaps inducing internalization. 
Several ligands have been identified for CD24 including P-selectin in cancer and immune 
cells (Aigner et al, 1997; Xia et al. , 2002), Ll in neuronal cells (Kleene et al. , 200 1) and 
Siglec- 1 0 in dendritic cells (Chen et al. , 2009). In future studies to investigate the role of 
CD24 in adipogenesis in vivo, CD24 could be activated by adding a ligand of CD24 to 
cultured stromal vascular fraction (SVF) cells or 3T3-L1 cells and detennining the change 
in adipogenesis. 
If the diet-induced obesity experiments were to be repeated, there should be 
several changes to the experimental design . The mice should be sacrificed by 
decapitation, without volatile anaesthetics, as to not affect the vasculature and possibly 
losing the pre-adipocyte population. In addition, analysis should focus on the SVF, rather 
then the W AT, to ensure the enrichment of mRNA from pre-adipocytes. A baseline of 
CD24 expression should be established by sampling the mice at time 0, before the 
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addition of a HFD or LFD. Some adipogenic genes are differentially expressed even 
before introduction to a HFD, which may partly explain why C57BL/6 mice can have 
varying responses to a HFD (Koza et al., 2006). Detennining baseline expression levels 
would help account for this variability and allow for a better analysis of changes in gene 
expression due to a HFD. 
Finally, a larger number of mice should be used, especially in the anti-CD24 Ab 
injection experiment, where only 6 animals were tested. A power test revealed that a 
sample of 8 is required for a power of 0.8 and significance of 0.5. There was a trend for 
increased CD24 mRNA in the anti-CD24 antibody injected mice, therefore if there was a 
larger sample, this may have been significant. In future experiments, more genes involved 
in adipogenesis, such as those involved in glucose transport and lipogenesis, should be 
also be examined to get a better overall indication of adipogenesis. 
To conclude, the data presented in this thesis demonstrate that CD24 is regulated 
during pre-adipocyte differentiation and that CD24 expression is inversely correlated with 
fully developed adipocytes. Furthennore, this is the first study to report the positive 
feedback regulation of antibody-mediated CD24 clustering leading to increased CD24 
expression. Future work is required to determine the signalling pathway regulating CD24 
expression in 3T3-LI pre-adipocytes, as well as to identify how CD24 is activated in vivo. 
Deciphering the precise role of CD24 in pre-adipocytes is important for determining the 
early molecular events regulating adipogenesis and contributing to the development of 
therapeutics to combat excess or paucity white adipose tissue. 
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Appendix 
6.0 Effects of western diet on CD24 expression 
The increase in CD24 expression in the first HFD experiment was observed 
concurrently with an increase in the pre-adipocyte marker Pref-1 and before an increase in 
any later markers of adipogenesis, suggesting that a HFD can increase CD24 expression 
at a very early time point during adipogenesis in vivo. Because W AT contains a 
heterogeneous population of cells, experiments were perfonned to try to identify the cell 
type in W AT with increased CD24 expression in response to a western diet (WD), a 
modified version of the HFD. The WD includes a variety of saturated fats, minerals and 
vitamins, making it isocaloric compared to the HFD and more similar to the diet 
consumed in western society as compared to the HFD. Five week old mice were used in 
an attempt to decrease the effect of animal development including hormonal effects that 
may affect adipogenesis at younger ages and because adiposity during the first 3 week of 
a HFD may not correlate with difference in food intake or feeding efficiency (Koza et al., 
2006). 
6.1 Materials and Methods 
6.1.1 Antibodies 
The antibodies (Abs) specific for CD24 (91), and all secondary ABS were 
purchased from Santa Cruz Biotechnologies (Santa Cruz, CA). The Abs specific for 
CD 11 b (Ml /70), PerCP-Cy 5.5 (Mac- 1 marker) and isotype control were purchased from 
eBioScience (San Diego, CA). 
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6.1.2 Animal Diets and Procedures 
5 week-old male C57BL/6 mice were fed a western diet (WD) containing 40% 
energy from fat (TestDiet®, Richmond, IN, 5TJN) or a control diet (LFC) containing 12% 
energy from fat (TestDiet®, Richmond, IN, 5TJS). Mice were sacrificed by cervical 
dislocation and the epididymal white adipose tissue (W AT) was immediately weighed and 
either frozen in liquid nitrogen for RNA extraction or minced in Krebs-Ringer Hepes 
Buffer (KRH) (Joost and Schtinnann, 200 I) for stromal vascular fractionation. All animal 
procedures were approved by Memorial University's Institutional Animal Care 
Committee. 
6.1.3 Stromal Vascular Fraction Isolation 
W AT in KRH buffer was minced using razor blades followed by incubation in 
KRH buffer containing 15mg type 1 collagenase (Life Technologies, Burlington, ON), at 
3 7°C for 1 hour with periodic shaking. W AT was then passed through a l 00 fA.M filter and 
centrifuged for 10 min at 200xg to pellet the stromal vascular fraction (SVF) while 
causing the mature adipocytes to float to the top. The mature adipocytes and interface 
were removed and the SYF was washed 3 times in KRH buffer, centrifuging for 8 min at 
400xg between each wash. After the final wash, the SYF pellet was re-suspended in 1 ml 
of KRH buffer and cells were stained with Tryphan Blue (Invitrogen), staining the dead 
cells, and non-stained cells were counted using a haemocytometer. 
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6.1.4 Flow Cytometry 
Cells (5x 106 cells/ml) were used for each analysis and all antibodies were diluted 
in FACS buffer (1% PBS +5% FBS) to a total volume of 100 !-!L Cells were incubated in 
I !-!g of CD24 (91) antibody for 30 min followed by AlexFluor 488 donkey-anti-rat 
antibody, 1: I 00, for 30 min. Cells were washed 3 times in F ACS buffer between all 
incubations. Cells were then incubated in 20!-!1 of normal rat serum (Santa Cruz 
Biotechnologies, sc-45135) for 20 min followed by I Oflg of Fab fragment Donkey-anti-rat 
lgG antibody (Jackson ImmunoResearch, 712-007-003) for 20 min . Finally, cells were 
incubated in 0.26flg of Mac-1 antibody for one hour. Isotype controls were incubated in 
Alexfluor 488 donkey-anti-rat antibody( 1: I 00) for 30 min, followed by normal rat serum 
for 20 min, Fab fragment for 20 min and Rat lgG2b K Isotype Control PerCP-Cy5.5 
(0.26f.lg) for one hour. A ll cells were re-suspended in 1% parafonnaldehyde and analyzed 
with a BD F ACSCalibur. Analysis was completed using Cyflogic (www.cyflogic.com). 
6.1.5 RNA Isolation, Dnase Treatment and eDNA synthesis. 
As completed in section 2.5. 
6.1.6 Quantitative PCR (qRT-PCR) 
As completed in section 6.5 . 
6.1. 7 Statistical Analysis 
Statistical analysis was perfonned using the Student's t-test. Differences were 
considered significant at p<0.05. Statistical analysis was determined using VassarStats 
(Lowry R., 20 1 0). 
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6.2 Results and Discussion 
6.2.1 Western diet increases expression of CD24 at a single cell level after 2 days of 
feeding 
Five week old C57BL/6 mice were fed a western diet (WD, 40% of energy from 
fat) or low fat control diet (LFC, 12% of energy from fat) for up to 42 days and mRNA 
and protein expression in the SVF of W AT was examined by qRT -PCR and flow 
cytometry, respectively. The use of flow cytometry allowed the examination of surface 
protein expression in cells from the SVF at a single cell level. As W AT is a heterogeneous 
population of cells, it is unknown if the increase in CD24 expression is on pre-adipocytes 
or another cell population within the W AT. Macrophages are located in adipose tissue and 
are known to express CD24; therefore the SVF was co-stained with antibodies for CD24 
and Mac-1 (CD ilb), a marker ofmacrophages, and analyzed by flow cytometry, to 
detennine if the increase in CD24 expression was on macrophages. 
Mice fed the WD ate significantly more kCal/day, were significantly heavier then 
LFC mice after 8 days of feeding, and had significantly more W AT after 42 days (Fig 20). 
There was no significant difference in mRNA levels ofCD24 or any adipogenic gene 
examined between diets until day 42 when there was an increase in PPARy suggesting 
that the WD may not be inducing adipogenesis compared to LFC (Fig. 21). The WD 
caused an increase in body weight after 8 days of feeing, but no change in W AT, while 
the HFD used in previous experiments, caused an increase in W AT after 1 week but no 
change in body weight. This may be due to the different diet compositions. The WD is 
composed of a variety of different fats , vitamins and minerals compared to the HFD, 
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Fig 20. Mice fed a western diet had increased caloric intake, body weight and WAT 
compared to LFC. Five week old C57BL/6 mice were fed a 12% energy from fat low 
fat control (LFC) or 40% energy from fat western diet (WD) for 1-42 days. a. Calorie 
intake in kCal/day b. Body weight of day 42 mice, c. WAT weight. Data in a. and c. 
shown as mean ± SE. Statistical significance was detennined using a Student t-test, n=4, 
*p<O.Ol , **p<0.05 
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Fig 2 1. Western d iet had no effect on CD24 mRNA expression or other adipogenic 
genes until day 42 when there was an increase in PPARy. mRNA expression in WAT of 
5 week old C57BL/6 mice fed a 12% energy from fat low fat diet (LFC) or a 40% energy 
from fat western diet (WD) for up to 42 days as determined by qRT PCR. Expression 
levels were normalized to RPLPO using the Pffafl equation and calculated relative to one 
LFC mouse. Data shown as mean ± SE. Statistical significance was determined using a 
Student t-test, n=4, *p<O.OS 
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which consists mostly of lard, and therefore one hypothesis is that the WD may have 
affected overall bone, muscle and adipose tissue growth differently then the HFD. 
Further, there was a high degree of variability in mRNA levels within groups making any 
biological effects on adipogenesis difficult to discern. As stated in section 1.2.1.1, 
different responses to a HFD have been found within strains of mice, which may account 
for the variability within groups, as wel l as the different response observed between the 
HFD and WD. 
There was no significant difference in the number of cells expressing CD24 
(CD24+) until day 42, when there was an increase in cells that expressed both CD24 and 
Mac-! (CD24+Mac+) in mice fed a WD (Fig. 22). Obesity is associated with low-grade 
chronic inflammation, therefore the increase in the CD24+Mac+ cell population after 42 
days of the WD was likely due to a recruitment of macrophages or neutrophils, 
contributing to inflammation during obesity (Subramanian, V., 2009). To determine if 
macrophage infiltration was the cause of increased CD24 expression after 42 days, mice 
could be injected intraperitoneally with clodronate liposome to deplete macrophages in 
the adipose tissue (Pang et al. , 2008), and expression of CD24 measured after 42 days of 
the WD. If no increase in CD24 expression was observed after 42 days of the WD, then 
the increase in CD24 expression was likely due to infiltration of macrophages expressing 
CD24. 
Analysis of protein expression at a single cell level, measured by mean 
fluorescence intensity (MFI), revealed a significant increase in high levels of CD24 
protein expression after 2 days of the WD (Fig. 23), followed by a decrease in expression 
levels by day 7. Examination ofMFI ofCD24 on the Mac+ cell population on day 2 
76 
a. b. 
80 LFC 70 
-
-70 I ~ 60 LFC ~ •wo 0 
-60 ~ 50 •wo Ill Qi ~50 I (J 40 (J + 
cJ 40 (J !a 30 ~ 30 :::ii: 
~ 20 ..t 20 ** I N N c c 10 (.) 10 (.) 
0 0 
2 7 14 42 2 7 14 42 
Days on Diet 
c. 
Days on Diet 
70 
~60 LFC 
* ~ 50 •wo 
Q) 
(J 40 
I + (J !a 30 
:::ii: I ~ 20 
N I 810 
0 
2 7 14 42 
Days on Diet 
Fig 22. No change in CD24 protein expressing cells was observed in mice fed a WD 
compared to the LFC until day 42. Protein levels of CD24 and Mac-1 , a macrophage 
marker, were detennined in the stromal vascular fraction (SVF) ofWAT from 5 week old 
C57BL/6 mice fed a 12% energy from fat low fat control (LFC) or a 40% energy from fat 
western diet (WD), by flow cytometry and expressed as percent populations. a. CD24+Mac-
cell population b. CD24-Mac+ cell population c. CD24+Mac+ cell population. Data shown 
as mean ± SE. Statistical significance was detennined using a Student t-test, n=4, *p<O.O 1, 
**p<O.OS 
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Fig 23. The amount of CD24 protein per cell increased after 2 days of WD but not on 
macrophages. Single cell analysis of protein expression in the stromal vascular fraction 
(SVF) ofWAT from 5 week old C57/BL mice fed a 12% energy from fat low fat control 
(LFC) or a 40% energy from fat western diet (WD) was detennined using flow cytometry 
and expressed as mean relative intensity of fluorescence of the specified protein. a. Cells 
expressing CD24 protein b. Cell expressing Mac- I protein, c. Expression of CD24 protein 
on Mac- 1 protein expressing cells on day 2. Data shown as mean ± SE. Statistical 
significance was detennined using a Student t-test, n=4, *p<0.05 
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detennined that the increase in high levels of CD24 protein was not on macrophages but 
another cell type in the SVF (Fig. 23c). 
Significant changes in mRNA levels were found in the HFD vs LFD experiment 
but not the WD vs LFC diet. There could be several reasons that may contribute to these 
differences. In the WD experiment, there was high variability between mice in each 
group, suggesting that a larger sample size may have been required for analysis. Again, 
variability in responses to a HFD has been observed within strains of mice (Koza et al., 
2006). The difference in diet compositions may have also had an effect on the rate of 
adipogenesis where the WD may be inducing adipogenesis, as well as muscle and bone 
growth, at a different rate compared to the HFD, although this has never been examined. 
Finally, the difference in the age of mice (3 week in the HFD vs 5 week in the WD) may 
have contributed to the different results. 
It is hard to discern any conclusions from this experiment as there was a large 
variability in the effects on adipogenic gene expression with this diet. In future 
experiments to address the cell type in W AT that expresses CD24, the stromal vascular 
fraction (SVF) should isolated from the WAT and magnetic cell sorting used to separate 
specific cells types, such as macrophages or pre-adipocytes. CD24 expression could then 
be analyzed to detennine which cell type is expressing CD24. 
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